Thyroid nodules grow when thyroid cells receive signals to multiply faster than normal. These signals can come from hormones, nutritional deficiencies, genetic changes within the nodule itself, or metabolic conditions like insulin resistance. Most benign nodules grow slowly or not at all: about 88% of benign nodules grow less than 2 mm per year. But understanding what drives that growth can help you make sense of what’s happening in your body and what factors you might be able to influence.
How TSH Drives Thyroid Cell Growth
Thyroid-stimulating hormone (TSH) is the primary signal telling your thyroid to work harder. When TSH binds to receptors on thyroid cells, it triggers a cascade of internal signals that push cells through their growth cycle and into division. TSH doesn’t act alone, though. It works in cooperation with insulin and a related compound called IGF-1 to activate the specific pathways that lead to DNA replication and cell proliferation.
This matters because anything that raises your TSH levels can accelerate nodule growth. If your thyroid is underperforming for any reason, your pituitary gland compensates by pumping out more TSH, which stimulates the thyroid tissue, including any existing nodules, to grow. This is one reason why untreated hypothyroidism and nodule enlargement often go hand in hand.
Iodine Deficiency and Compensatory Growth
Iodine is an essential building block of thyroid hormones. When your body doesn’t get enough iodine, the thyroid can’t produce adequate hormone levels. At first, the gland draws on its stored reserves. But once those run out and circulating hormone levels start to drop, the pituitary responds by increasing TSH output. That extra TSH stimulates the thyroid to trap more iodine and ramp up hormone production, but it also drives the gland to enlarge. Over time, this compensatory growth can produce nodules or cause existing ones to expand.
In regions where iodine intake is sufficient, this mechanism is less common. But mild iodine insufficiency still exists in parts of Europe and other areas, and it remains one of the most well-established causes of thyroid enlargement worldwide.
Insulin Resistance and Nodule Size
If you have insulin resistance or type 2 diabetes, your thyroid nodules may grow faster. Research published in the International Journal of Endocrinology found a strong positive correlation between insulin resistance (measured by a standard index called HOMA-IR) and both thyroid nodule volume and size, regardless of gender. The correlation was striking, with an r value of 0.808, meaning insulin resistance explained a large share of the variation in nodule size among the patients studied.
The mechanism works like this: insulin resistance leads to chronically high insulin levels. That excess insulin interacts with binding proteins in a way that increases the amount of free IGF-1 circulating in your blood. IGF-1 is a potent growth factor for many cell types, including thyroid cells. Higher free IGF-1 levels essentially give nodules more fuel to grow. The researchers concluded that reducing insulin resistance could slow nodule growth rate and minimize nodule volume, which suggests that managing blood sugar and metabolic health has a direct connection to what happens in your thyroid.
Estrogen and the Female Thyroid
Women develop thyroid nodules and thyroid cancers far more often than men, and the difference is most pronounced between puberty and menopause. Thyroid cancers are three times more common in women, and peak rates occur earlier in life compared to men. This pattern points strongly to estrogen as a contributing factor.
Estrogen promotes thyroid cell proliferation through receptor-dependent mechanisms. Thyroid cells have two types of estrogen receptors that play opposing roles: one type promotes cell growth and division, while the other promotes cell death and suppressive functions. The ratio between these two receptor types appears to influence whether estrogen exposure tips toward nodule growth or stays in check. Periods of high estrogen exposure, such as pregnancy or hormone replacement therapy, may create conditions that favor thyroid cell proliferation.
Genetic Mutations Inside the Nodule
Some nodules grow because of genetic changes in the thyroid cells themselves. In “hot” nodules (those that overproduce thyroid hormone), the most common cause is a mutation in the TSH receptor gene. This mutation locks the receptor in an “always on” position, activating growth and hormone production pathways continuously, even without TSH stimulation from the pituitary. The result is a nodule that grows autonomously.
Growth factors like EGF, TGF-alpha, and IGF-1 likely play a larger role during the early stages of nodule development, helping a small cluster of cells expand. As the nodule matures, a dominant somatic mutation (like the TSH receptor mutation) takes over as the primary driver of growth advantage. This is why some nodules seem to accelerate after years of being stable: the genetic landscape within the nodule itself can shift over time.
Hashimoto’s Thyroiditis and Inflammation
Hashimoto’s thyroiditis, the most common cause of hypothyroidism in the United States, creates a chronically inflamed thyroid environment. The immune system gradually destroys thyroid tissue, which forces the remaining cells to compensate. This cycle of destruction and attempted regrowth can lead to nodule formation, though interestingly, nodules in Hashimoto’s patients tend to be slightly smaller on average (2.34 cm vs. 2.71 cm) than nodules in people without the condition. The overall gland also tends to be smaller, averaging about 30 grams compared to nearly 40 grams in non-Hashimoto’s patients.
The relationship between Hashimoto’s and nodule growth is complex. The hypothyroidism caused by the disease raises TSH, which stimulates growth. But the ongoing immune destruction works against that growth. The net result varies from person to person, and Hashimoto’s patients need consistent monitoring because the inflammatory environment may also increase the risk of certain thyroid cancers.
How Fast Benign Nodules Typically Grow
Most thyroid nodules are slow movers. Data highlighted by the American Thyroid Association shows that 88% of benign nodules grow less than 2 mm per year or don’t grow at all. Among cancerous nodules, the percentage that stayed below that threshold was still 74%, which is why growth rate alone isn’t a reliable way to distinguish benign from malignant nodules.
Clinically significant growth is defined as either more than 2 mm per year, a 20% or greater increase in at least two dimensions, or a 50% or greater increase in nodule volume. About 12% of benign nodules and 26% of cancerous nodules exceeded the 2 mm per year threshold. If your nodule crosses these benchmarks on follow-up ultrasound, a repeat fine-needle aspiration biopsy is typically recommended to rule out malignancy, even if a previous biopsy was benign.
Selenium and Nodule Size
Selenium, a trace mineral involved in thyroid hormone metabolism, has shown modest promise in slowing nodule growth. In a clinical study of patients with benign thyroid nodules, those taking 100 micrograms of selenium daily experienced a significant reduction in average nodule length (from 17.1 mm to 14.9 mm). Those taking 200 micrograms saw a significant decrease in nodule height and volume, with volume dropping from 0.82 mL to 0.78 mL. The control group showed no change.
These are small but statistically significant reductions. Selenium’s role in thyroid health is already well established (it’s essential for the enzymes that convert thyroid hormones), so adequate selenium intake through foods like Brazil nuts, seafood, and eggs supports normal thyroid function. Whether supplementation beyond adequate intake meaningfully shrinks nodules over the long term still needs more study, but the early signal is encouraging for people with confirmed benign nodules looking for conservative options.
What You Can Influence
Some growth drivers, like somatic mutations, are beyond your control. But several of the most powerful factors are modifiable. Ensuring adequate iodine intake prevents the compensatory TSH surge that fuels thyroid enlargement. Managing insulin resistance through diet, exercise, and weight management directly addresses one of the strongest correlates of nodule size. Keeping thyroid hormone levels optimized (which keeps TSH from climbing too high) removes the most basic hormonal stimulus for nodule growth.
If you have a known nodule, regular ultrasound monitoring gives you and your doctor a clear picture of whether it’s growing and how fast. A nodule that stays stable for years is reassuring. One that crosses the growth thresholds, particularly more than 2 mm per year or a 50% volume increase, warrants a closer look regardless of what a previous biopsy showed.